Anna Mania

Dr. Anna Mania

Department of Infectious Diseases and Child Neurology, Poznan University of Medical Sciences
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Advances in Dermatology and Allergology
Verified
Journal Article
Open access
Katarzyna Mazur-MelewskaKatarzyna Mazur-Melewska
Katarzyna Mazur-Melewska
Anna ManiaAnna Mania
Anna Mania
PKPaweł Kemnitz
Paweł Kemnitz
MFMagdalena Figlerowicz
Magdalena Figlerowicz
WSWojciech Służewski
Wojciech Służewski
The aim of this review is to present an emerging zoonotic disease caused by Bartonella henselae . The wide spectrum of diseases connected with these bacteria varies from asymptomatic cases, to skin inflammation, fever of unknown origin, lymphadenopathy, eye disorders, encephalitis and...

1 January 2014 in Infection, Genetics and Evolution
Verified
Journal Article
Closed access
PJPaulina Jackowiak
Paulina Jackowiak
KKKarolina Kuls
Karolina Kuls
LBLucyna Budzko
Lucyna Budzko
Anna ManiaAnna Mania
Anna Mania
MFMagdalena Figlerowicz
Magdalena Figlerowicz
MFMarek Figlerowicz
Marek Figlerowicz

28 October 2015 in Journal of Child Neurology
Verified
Journal Article
Closed access
Katarzyna Mazur-MelewskaKatarzyna Mazur-Melewska
Katarzyna Mazur-Melewska
IBIwona Breńska
Iwona Breńska
KJKatarzyna Jonczyk-Potoczna
Katarzyna Jonczyk-Potoczna
PKPaweł Kemnitz
Paweł Kemnitz
IPIlona Pieczonka-Ruszkowska
Ilona Pieczonka-Ruszkowska
MFMagdalena Figlerowicz
Magdalena Figlerowicz
We retrospectively analyzed the medical documentation of 194 children infected with Epstein-Barr virus. The diagnosis was based on clinical symptoms and the presence of the viral capsid antigen IgM antibody. Patients with severe neurologic complications also underwent neurologic examination, magnetic resonance imaging (MRI), and electroencephalography (EEG). There were 2 peaks in incidence of infection; the first one in young children aged 1 to 5 years represented 62.0% of cases. The second peak (24.6% of patients) occurred in teenagers. Febrile seizures were confirmed in 3.1% of affected children younger than 5 years and headaches in 24.2% patients, mostly older children. Ten children presented severe, neurologic complications: meningoencephalitis, acute encephalitis, acute cerebellitis, transverse myelitis, and myeloradiculitis. Our study identified a variety of Epstein-Barr virus–related neurologic complications. Epstein-Barr virus should be routinely tested for when a child presents with an apparent neuroinfection as it is a common pathogen that can induce a wide variety of signs and symptoms.

22 October 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MOMagdalena Okarska-Napierała
Magdalena Okarska-Napierała
Kamila LudwikowskaKamila Ludwikowska
Kamila Ludwikowska
LSLeszek Szenborn
Leszek Szenborn
NDNatalia Dudek
Natalia Dudek
Anna ManiaAnna Mania
Anna Mania
Ernest P. KucharErnest P. Kuchar
Ernest P. Kuchar
Pediatric inflammatory multisystem syndrome (PIMS) is a new entity in children, likely associated with previous coronavirus disease 19 (COVID-19) infection. Most of the reports about PIMS come from countries particularly hit by the COVID-19 pandemic. Our aim was to investigate the nature of inflammatory syndromes in Poland (country with low COVID-19 prevalence) and to perceive the emergence of PIMS in our country. On 25 May 2020, we launched a nationwide survey of inflammatory syndromes in children for retrospective (since 4 March 2020) and prospective data collection. Up to 28 July, 39 reported children met the inclusion criteria. We stratified them according to age (<5 and ≥ 5 years old) and COVID-19 status. The majority of children had clinical and laboratory features of Kawasaki disease, probably non-associated with COVID-19. However, children ≥5 years of age had PIMS characteristics, and nine children had COVID-19 confirmation. This is, to our knowledge, the first report of the PIMS register from a country with a low COVID-19 prevalence, and it proves that PIMS may emerge in any area involved in the COVID-19 pandemic. In a context of limited COVID-19 testing availability, other risk factors of PIMS, e.g., older age, should be considered in the differential diagnosis of inflammatory syndromes in children.

1 March 2021 in Journal of Infection and Public Health
Verified
Journal Article
Open access
Anna ManiaAnna Mania
Anna Mania
KMKatarzyna Mazur-Melewska
Katarzyna Mazur-Melewska
Karol Franciszek LubarskiKarol Franciszek Lubarski
Karol Franciszek Lubarski
JKJadwiga Kuczma-Napierała
Jadwiga Kuczma-Napierała
JMJustyna Mazurek
Justyna Mazurek
MFMagdalena Figlerowicz
Magdalena Figlerowicz
Children account for a relatively small proportion of laboratory-confirmed SARS-CoV-2 infections. In children, COVID-19 usually has a relatively mild course. However, in rare cases, severe disorders can be observed, and clinical manifestations may differ from adults. The aim of this study is to analyse the frequency, clinical picture and outcome of COVID-19 in children based on the experience from the tertiary care centre and regional sanitary-epidemiological office. We report a study regarding 106 cases of confirmed SARS-CoV-2 infection cases in PCR from a nasopharyngeal swab (age range 1-month – 17-years). In all cases, history was taken. In children who required hospital admission, physical examination and laboratory test were performed according to clinical indications. Twelve of the patients required admission to the hospital. The most common symptoms were anosmia and dysgeusia (75%) and headaches (49%) in outpatients and fever in hospitalised children (75%). Three children from the hospitalised group developed a severe course with increased inflammatory indexes. The clinical picture was more severe in younger children from the hospitalised group. Treatment options were regarded individually in all cases. Our study is the first tour knowledge regarding the clinical course of COVID-19 in Polish children. In general, the clinical course of COVID-19 was mild with anosmia and dysgeusia as the most common symptoms. However, in hospitalised children, a severe progression of the disease and less typical signs as aplastic anaemia may be developed.

17 February 2015 in Child's Nervous System
Verified
Journal Article
Open access
PDF file
Katarzyna Mazur-MelewskaKatarzyna Mazur-Melewska
Katarzyna Mazur-Melewska
KJKatarzyna Jonczyk-Potoczna
Katarzyna Jonczyk-Potoczna
KSKrystyna Szpura
Krystyna Szpura
GBGrzegorz Biegański
Grzegorz Biegański
Anna ManiaAnna Mania
Anna Mania
MFMagdalena Figlerowicz
Magdalena Figlerowicz
Transient signal changes in magnetic resonance imaging (MRI) of the splenium of the corpus callosum (SCC) can result from many different reasons, including encephalitis and encephalopathy caused by infection, seizures, metabolic disorders and asphyxia. We report a case of a 6-year-old Polish girl with rotavirus infection demonstrating a reversible SCC lesion on diffusion-weighted MRI images. She presented six episodes of generalized tonic seizures with mild acute gastroenteritis. Stool test for rotavirus antigen was positive. At the time of admission imaging showed the hyperintense region in T2-weighted and fluid-attenuated inversion-recovery MRI, a well-defined lesion in the splenium of the corpus callosum with restricted diffusion in diffusion-weighted MRI and no enhancement in post contrast T1-weighted imaging. Her first EEG showed slow brain activity in the posterior occipitotemporal portion, consisting mainly of theta waves with a frequency of 4.5–5.5 Hz and amplitude of 40 uV. The lesion had completely disappeared on follow-up MRI 10 days later. The patient recovered fully without any sequelae.